2-(ethylthio)-4,5-bis(4-methoxyphenyl)imidazole | 62894-32-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 2-(ethylthio)-4,5-bis(4-methoxyphenyl)imidazole
• 英文别名: 4,5-bis(4-methoxyphenyl)-2-(ethylthio)imidazole；2-ethylsulfanyl-4,5-bis-(4-methoxy-phenyl)-1H-imidazole；2-Ethylthio-4,5-bis(4-methoxyphenyl)imidazole；2-ethylsulfanyl-4,5-bis(4-methoxyphenyl)-1H-imidazole
• CAS: 62894-32-0
• 化学式: C₁₉H₂₀N₂O₂S
• 分子量: 340.446
• InChiKey: GIXYKLJTZGUBLX-UHFFFAOYSA-N

物化性质

• 熔点：
  109-129 °C
• 沸点：
  521.3±60.0 °C(Predicted)
• 密度：
  1.24±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  24
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  72.4
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-(ethylthio)-4,5-bis(4-methoxyphenyl)imidazole 在 间氯过氧苯甲酸 作用下， 以 二氯甲烷 为溶剂， 生成 2-ethanesulfinyl-4,5-bis-(4-methoxy-phenyl)-1H-imidazole
  参考文献：
  名称：

  Anti-inflammatory 4,5-diarly-2-(substituted-thio)imidazoles and their

  摘要：

  抗炎4,5-二芳基-2-(取代硫)咪唑及其对应的亚砜和磺酰化物，用于治疗关节炎和相关疾病。

  公开号：

  US04190666A1
• 作为产物：
  描述：

  碘乙烷 、 4,5-双(4-甲氧基苯基)-1,3-二氢咪唑-2-硫酮 在 sodium methylate 作用下， 生成 2-(ethylthio)-4,5-bis(4-methoxyphenyl)imidazole
  参考文献：
  名称：

  4,5-二芳基-2-（取代硫代）-1H-咪唑及其亚砜和砜的制备及其抗关节炎和止痛作用。

  摘要：

  合成了一系列的4,5-二芳基-2-（取代硫代）-1H-咪唑，并在大鼠佐剂诱导的关节炎试验和小鼠苯基-对苯醌扭曲（PQW）试验中用作抗炎和镇痛药。发现几种类似物比苯基丁a和消炎痛更有效。讨论了构效关系。发现其中一种化合物4,5-双（4-氟苯基）-2-[（（1,1,2,2-四氟乙基）-磺酰基] -1H-咪唑（8d，tiflamizole）是在大鼠佐剂诱导的关节炎试验中具有消炎痛的作用，目前正在作为抗关节炎药进行临床试验。

  DOI：

  10.1021/jm00147a011

文献信息

• 5,6-Diaryl-2,3-dihydroimidazo[2,1-b]thiazoles: a new class of immunoregulatory antiinflammatory agents
  作者：Paul E. Bender、David Hill、Priscilla H. Offen、Kazys Razgaitis、Patricia Lavanchy、Orum D. Stringer、Blaine M. Sutton、Don E. Griswold、Michael DiMartino

  DOI：10.1021/jm00147a008

  日期：1985.9

  A series of substituted 5,6-diaryl-2,3-dihydroimidazo[2,1-b]thiazoles were synthesized and evaluated in the rat adjuvant-induced arthritis and mouse oxazolone-induced contact sensitivity assays to determine the potential of these compounds for use as immunoregulatory antiinflammatory agents. This class of compounds was derived by combining salient structural features of the antiinflammatory agent flumizole and the immunoregulatory drug levamisole. Unlike the latter two, a number of compounds in the target series were found to possess the desired combination of activities. Exploration of structure-activity relationships in the adjuvant-induced arthritic rat assay revealed that optimal potency was exhibited by symmetrically substituted 5,6-diaryl compounds having one of the following alkyl heteroatom or halogen functions at the para position: methoxy, ethoxy, methylthio, N-ethyl-N-methylamino, fluoro, or chloro. Scrambling of these two substituent classes to yield the asymmetrically substituted 5,6-diaryl compounds resulted in potent activity only with the 5-alkyl heteroatom, 6-halo-substituted regioisomers. However in the oxazolone-induced contact sensitivity assay, no consistent relationship of variation in activity with structural change was apparent. The initial target compound 5,6-bis(4-methoxyphenyl)-2,3-dihydroimidazo[2,1-b]thiazole (1) was compared with its progenitors in additional models of inflammation and immunoregulation.
• BENDER, P. E.;HILL, D. T.;OFFEN, P. H.;RAZGAITIS, K.;LAVANCHY, P.;STRINGE+, J. MED. CHEM., 1985, 28, N 9, 1169-1177
  作者：BENDER, P. E.、HILL, D. T.、OFFEN, P. H.、RAZGAITIS, K.、LAVANCHY, P.、STRINGE+

  DOI：——

  日期：——
• SHARPE, T. R.;CHERKOFSKY, S. C.;HEWES, W. E.;SMITH, D. H.;GREGORY, W. A.;+, J. MED. CHEM., 1985, 28, N 9, 1188-1194
  作者：SHARPE, T. R.、CHERKOFSKY, S. C.、HEWES, W. E.、SMITH, D. H.、GREGORY, W. A.、+

  DOI：——

  日期：——
• US4190666A
  申请人：——

  公开号：US4190666A

  公开（公告）日：1980-02-26
• US4269847A
  申请人：——

  公开号：US4269847A

  公开（公告）日：1981-05-26